Diabetes News and Research

Latest Diabetes News and Research

Study finds patients more likely to skip diabetes medicine while in the 'doughnut hole'

Consumers experiencing a gap in their Medicare Part D prescription drug coverage were more likely to forgo diabetes medications than those who had supplemental drug benefits.

9 Jan 2010

Health policy research roundup: Long-term care, diabetes disparities, health IT

Annals of Internal Medicine: Cultural Competency Training and Performance Reports to Improve Diabetes Care for Black Patients - In this study, researchers measure the effects cultural competency training and performance training for physicians has on the clinical outcomes for black patients with diabetes.

8 Jan 2010

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50 million. Scientists and clinicians at The University of Texas Health Science Center at Houston can address the diagnosis and treatment of these conditions, as well as the latest advances in research.

8 Jan 2010

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers have become the world's fifth most prolific contributors to peer-reviewed scientific literature on clock-reversing regenerative medicine even as a skeptical international research community condemns the practice of Chinese clinics administering unproven stem cell therapies to domestic and foreign patients.

8 Jan 2010

King Center to host second annual 'Health and Wellness Forum'

The King Center announced that it will officially launch the 2010 MLK Birthday Observance on Saturday, Jan. 9, 2010 by hosting and co-sponsoring its second annual “Health and Wellness Forum.” It is being co-sponsored by a $50,000 grant from Aetna, which also funded last year’s inaugural program.

8 Jan 2010

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

MicroCHIPS, Inc., a developer of intelligent implant systems, has raised $16.5 million to fund its lead programs in diabetes and osteoporosis. Current investors Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital were joined by new investor InterWest Partners.

8 Jan 2010

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Contrary to the widely-held belief, there is no proof that non-insulin-dependent patients with type 2 diabetes benefit from glucose self-monitoring. Moreover, it remains unclear whether an additional benefit is displayed by the blood test compared to the urine test or vice versa, in other words, whether one or other of the tests might offer an advantage to patients.

8 Jan 2010

Proteostasis Therapeutics enters into exclusive license agreement with New York University

Proteostasis Therapeutics announced today that it has entered into an exclusive license agreement with New York University for intellectual property related to discoveries from the laboratory of David Ron, M.D., Professor of Medicine and Julius Raynes Professor of Cell Biology at NYU Langone Medical Center’s Skirball Institute of Biomolecular Medicine.

8 Jan 2010

Sciele Pharma announces the U.S. availability of Adrenaclick

Sciele Pharma, Inc., a Shionogi company, today announced the U.S. availability of Adrenaclick™, a single-dose, epinephrine auto-injector for the emergency treatment for severe allergic reactions (Type I) such as anaphylaxis.

8 Jan 2010

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.

8 Jan 2010

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

A new national survey reveals that while almost all Canadians understand the importance of getting checked for colon cancer, most have not had a screening test and are confused about how and when it should happen.

8 Jan 2010

Exercise, nutrition and hormone optimization are key to improve men's health issues

Grant Mansell was 46 and frustrated with his 300 pound physique, ensuing back pain, rising cholesterol, dependency on blood pressure medicine but most of all not enjoying life with his wife and children.

8 Jan 2010

Hi-Tech Pharmacal receives clearance from FDA to market Tropazone lotion

Hi-Tech Pharmacal Co., Inc. announced today that it received clearance from the FDA to market Tropazone™ lotion, a prescription dermatological product which will be promoted by Hi-Tech’s branded marketing subsidiary, ECR Pharmaceuticals Co., Inc. The product is indicated for the treatment of various dermatological conditions including atopic dermatitis, allergic contact dermatitis, and radiation dermatitis.

8 Jan 2010

Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced

Elixir Pharmaceuticals, Inc. announced today that its partner, Siena Biotech S.p.A., has commenced Phase 1 clinical testing of Elixir’s potent, first-in-class SIRT1 (sirtuin-1) inhibitor for the treatment of Huntington’s Disease.

8 Jan 2010

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata’s lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.

8 Jan 2010

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.

8 Jan 2010

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure.

7 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

LIVESTRONGTM.COM compiles tools to help users maintain healthy living

Each year, millions of people designate January 1 as the day they are going to make a change. Stop smoking. Save money. Exercise regularly. Whatever the pledge, countless Americans try—and frequently fail—to make changes in their lives. Most start strong, but by February have all but abandoned their newfound goals.

7 Jan 2010

Scientists develop first-of-its-kind cloth that releases nitric oxide gas

Scientists in Texas are reporting development of a first-of-its-kind cloth that releases nitric oxide gas - an advance toward making therapeutic socks for people with diabetes and a wrap to help preserve organs harvested for transplantation. The study is in ACS' Chemistry of Materials, a bi-weekly journal.

7 Jan 2010

Diabetes News and Research

Latest Diabetes News and Research

Study finds patients more likely to skip diabetes medicine while in the 'doughnut hole'

Health policy research roundup: Long-term care, diabetes disparities, health IT

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

King Center to host second annual 'Health and Wellness Forum'

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Proteostasis Therapeutics enters into exclusive license agreement with New York University

Sciele Pharma announces the U.S. availability of Adrenaclick

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

Exercise, nutrition and hormone optimization are key to improve men's health issues

Hi-Tech Pharmacal receives clearance from FDA to market Tropazone lotion

Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

LIVESTRONGTM.COM compiles tools to help users maintain healthy living

Scientists develop first-of-its-kind cloth that releases nitric oxide gas

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in